11th
August 2006 NextGen makes strategic move into gene synthesis market
28th
June 2006
NextGen Group plc AGM statement
9th
June 1006
NextGen boost sales and marketing efforts through new senior management
appointments
24th
May 2006
Maiden final results for the year ending 31 December 2005
10th
January 2006 NextGen
Group PLC and Proteomic Research Services Inc (PRS) of Michigan,US,
announce that they have entered into a Commercial Alliance Agreement.
30th
December 2005 NextGen
Group PLC announces that it has successfully completed its fundraising
and admission to the AIM market of the London Stock Exchange.
26th
October 2005 NextGen
Sciences launches contractexpress™–
a new contract service business for multiparallel gene cloning and
protein expression
17th
October 2005 NextGen
Sciences launches the baculoworkstation-the first automated platform
for baculovirus expression
more - read the press release
16th
August 2005
NextGen
Sciences announces the appointment of new Chief Executive Officer
23rd
May 2005
NextGen
Sciences announces the launch of new "automation-friendly”
consumable products, designed to maximise throughput and productivity
for protein expression
21st
February 2005 NextGen
Sciences receives the Frost & Sullivan Technology Leadership Award
for 2005
10th
January 2005
NextGen Sciences licences flashBAC™, a break-through
technology for protein expression from Oxford Brookes University in
collaboration with the Natural Environment Research Council’s
Centre for Hydrology and Ecology, Oxford.
13th
October 2004 NextGen Sciences introduces the a2DEoptimizer™, an
advanced tool for 2-dimensional electrophoresis.
30th
September 2004 NextGen
Sciences Ltd introduces a new suite of revolutionary tools for molecular
biology and protein research.
16th
September 2004
NextGen Sciences announces the signing of new distribution agreements
10th
June 2004
NextGen Sciences Ltd announces the purchase of an expressionfactory
by GlaxoSmithKline.
20th
May 2004
NextGen Sciences today announced that it has been granted a patent
to protect the electrophoretic separation technology used in the company’s
a2DE system.
